Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | Kalorama Reports | A Guide to Drug Pricing and Reimbursement

A Guide to Drug Pricing and Reimbursement

Drug pricing is one of the key levers that determine the profitability of a drug company. Premium pricing of a new drug helps cover the high cost of innovation and helps run a profitable enterprise. But the recent onslaught of generics, as well as shrinking government and corporate healthcare budgets, is threatening the time-tested models, leading to higher pricing pressures for pharmaceutical and biotech companies in the coming years. In this environment, executives in these companies and the consultants who service them need better information to make the most profitable decisions.

Kalorama Information's A Guide to Drug Pricing and Reimbursement provides considerable detail on the this all-important area of pharmaceutical marketing strategy. The guide describes pricing strategies for specific results, including:

> Gaining Market Share

> Defending Market Share

> Enhancing Brand Loyalty

> Gaining New Customers

> Improving Margins

> Utilizing Capacity

The result of exhaustive research into recent pricing trends as well as interviews with top pharmaceutical executives, the Guide provides executives in pricing decision capacities with critical information needed to arrive at the most effective strategy:

> Useful statistics detailing the Overall Pharmaceutical Pricing Environment, including Healthcare Expenditures, Pharmaceutical Expenditures and Drug Prices in Select Countries as well as Biopharmaceutical R&D Expenditures

> Updated Medicare Reimbursement Information for Parts A,B,C and D

> The Development phases in which it is most important to consider pricing

> Overview of U.S. Pharmaceutical Market (including Healthcare Spending, Promotional Spending, Average Co Payments, Generic Drug Trends, Single Source Brand Vs. AWP and more.)

> Pricing Strategies for the European Market

> Japanese Market Pricing and Reimbursement Strategies.

Drug pricing and reimbursement also differs widely across the globe due to the huge disparity in economic situations of various countries, and this global report addresses the pricing environments in:

> U.S

> Europe

> Japan

Pricing and reimbursement will remain one of the most talked about industry issues going into the next decade. This report aims to provide a holistic view on pricing and reimbursement across the globe. This report enables executives to make proactive decisions and to craft their responses to the changing dynamics of the market.

September 1, 2007

200 Pages - Pub ID: KLI1422997 Format PDF
Table of Contents
Sample Pages
Price: $1,995.00 / €1,333.46

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions